<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To evaluate the feasibility of percutaneous thrombectomy for the removal of floating iliocaval <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> using a balloon sheath </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: A newly developed balloon sheath (inner diameter: 12-F; outer diameter: 18-F) was tested in two patients with extensive iliocaval <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Mechanical thrombectomy was performed due to recurrent <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> under therapeutic anticoagulation in <z:hpo ids='HP_0003613'>antiphospholipid-antibody</z:hpo> syndrome and, respectively, paraneoplastic <z:mp ids='MP_0005048'>thrombosis</z:mp> without a decrease of fresh <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> mass in spite of pharmacological treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Via a transjugular access (20-F), the sheath was advanced retrogradely into the inferior vena cava </plain></SENT>
<SENT sid="4" pm="."><plain>After blocking of the vessel, mechanical fragmentation was performed through the working channel coaxially, using a temporary vena cava filter as a rotating basket (max. diameter: 30 mm) </plain></SENT>
<SENT sid="5" pm="."><plain>Residual <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> fragments were removed by <z:hpo ids='HP_0002835'>aspiration</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The thrombectomy balloon sheath tested allowed a complete removal of fresh <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> after fragmentation </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, older clot material was obtained </plain></SENT>
<SENT sid="8" pm="."><plain>Balloon occlusion prevented the central embolization of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> fragments </plain></SENT>
<SENT sid="9" pm="."><plain>Clinical signs indicating <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> were not seen </plain></SENT>
<SENT sid="10" pm="."><plain>The fluid loss due to <z:hpo ids='HP_0002835'>aspiration</z:hpo> was negligible </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The newly developed 12-F balloon sheath proved to be efficient for the extraction of large <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Balloon occlusion safely prevented central embolization of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> fragments proximal to the sheath </plain></SENT>
</text></document>